TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Shunfeng's "drug delivery" challenge: guangdong's drug watchdog named local traditional medicine to fight back
 
Author:中国铭铉 企划部  Release Time:2017-6-6 8:32:00  Number Browse:467
 
Medical network - June 5 incoming medicine was checked, motion response to business not affected, the local drug group of companies have unity, to set up cold chain alliance back across the province. 
 
Third party logistics are back. On the one hand, there are high profile moves into the circulation of medicine, while some local traditional pharmaceutical wholesalers have been set up to establish cross-provincial cold chain fighting back. At this point, the logistics of shunfeng medical logistics have been accidentally examined. 
 
Recently, the guangdong food and drug administration issued a notice on the improvement of the drug GSP deadline (no. 73 in 2017). The 14 companies, including the "shunfeng pharmaceutical supply chain co., LTD.", which has just received a third party logistics qualification for pharmaceutical products. Motion, however, the response of media not only emphasize its pharmaceutical warehousing, transportation and other logistics operation is not affected, also expressed the hope that become the innovation practice of medical circulation industry and an important participant. 
 
Guangdong's pharmaceutical inspection bureau named shunfeng medicine 
 
Recently, the guangdong food and drug administration issued a notice on the improvement of the drug GSP deadline (no. 73 in 2017). In the follow-up examination of guangdong food and drug administration, 14 drug companies were ordered to complete the correction within one month after they did not comply with GSP regulations. The 14 companies, including the "shunfeng pharmaceutical supply chain limited", have just received a third party logistics qualification. 
 
, motion controlling, said food drug administration of guangdong province on April 26 to visit along abundant pharmaceutical supply chain co., LTD., routine checking, inspection found that the general defect item 1, for "the failure of 03402 enterprises have a document of quality management in work site", suitable abundant pharmaceutical supply chain co., LTD., on April 27, has been the process failure file is invalid, and handle filing separately, the rectification results on the submitted to guangdong food and drug administration. 
 
The company also said yesterday that the company had conducted a comprehensive review of internal document management and a second review to ensure strict implementation of the relevant management system. And stressed that the check, the suitable abundant medical quality management system, equipment management, site operation specifications and personnel qualifications are in line with the GSP requirements, pharmaceutical warehousing, transportation and other logistics operation is not affected. 
 
Motion in 2016 annual report showed that cold operators income grew by 93.03% year on year, motion controlling have two medicine, cold storage, 12 main pharmaceutical, medicine, cold storage and transit depot operating area of 2.5 square meters, over 227 vehicles of GSP certification. 
 
Motion controlling further said that at present, the suitable abundant medical network covering the whole country more than 960 administrative region, county, and service throughout the country more than 400 pharmaceutical industry enterprises, the future plans on this basis, continue to upgrade and meet the requirements of the GSP pharmaceutical logistics network, want to be innovative practice of medicine circulation industry and important players. 
 
Local traditional medicine batch want to be a group to respond? 
 
In the case of traditional pharmaceutical logistics enterprises, the intervention of shunfeng has made a relatively stable market more uncertain. It is in this context that local pharmaceutical companies, which have been forced to transform by the New Deal, are already set up to form a trans-provincial cold chain alliance. 
 
"In the biography, by the industry does a few boss said before also do medical business, which may in the company engaged in vaccine, in vitro diagnostic reagent, and the distribution of antitumor drugs, but the two votes such as policy, as well as the motion intervention, prompt them to consider established union." So says the head of a domestic pharmaceutical logistics company. 
 
Sinopharm, however, a senior fellow at the dry RongFu admitted that if the pharmaceutical distribution alliance and the emergence of pharmaceutical retail federation is mainly to cope with two votes, commercial companies and pharmaceutical companies to build cold chain alliance also has some significance. So there is a limit to the fact that regional business companies are cross-provincial cold chain alliances, and they do not rule out speculation. 
 
It is well known that drug distribution is often heated and cold, and the national pharmaceutical distribution giants, such as China pharmaceutical holdings, China resources medicine and jiuzhou tong, will have coverage. Shunfeng has a national network in the cold chain, and is already fast moving into medicine. In addition, the trans-provincial cold chain alliance must have the input of cold chain equipment, which is expected to be relatively loose in the form of the alliance. 
 
What are the challenges of delivering drugs? 
 
In some in the industry point of view, the biggest competitor before motion is really the several big national pharmaceutical distribution, in addition, how to recover the huge investment is also a motion to be thinking about. 
 
Dry RongFu revealed that the current domestic market the entire pharmaceutical circulation is 1.6 trillion, and growth has been less than 10%, average net income in the pharmaceutical business 1. 6 points. The only way to get involved is to cut the cake. Because drug distribution involves GSP problems, drug delivery must have a pharmacy terminal. Because, according to the latest Internet and medical regulations, the "shop" can only be a physical retail pharmacy. 
 
"What is the most difficult regulation on transport. Pharmaceutical cold chain for traditional express pharmaceutical logistics layout, also need to be information docking and reserve professional pharmaceutical logistics talents, and to do a good job stability test and so on, such as in the practice of the whole cold chain, sometimes do less than 100% cold-chain transportation, so, in the cold chain transportation, how long time will have an impact on drug quality exposed? These questions are need to do in-depth research." Yao tong, general manager of the cold chain division of tongzhou medical group, points out. 
 
However, yao has also pointed out that, along abundant medicine is related to its big strategic layout, related to its listed after the need to find new profit point, but in the long term, the motion intervention, is expected to raise the level of the entire pharmaceutical business logistics, promote industry upgrade. 

 
Previous article:Global sales of more than $1.1 billion and a first line of antiviral drugs have been approved
Next article:The report came in the first quarter, and the drug company made $1 billion
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号